Skip to main
VBIO

VBIO Earnings Dates & Reports

VBIO Most Recent Earnings

Report Date
Period EndingQ3 2023
Est. EPS-$119
Actual EPS-$25.16
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

VBIO Earnings per Share (EPS) History

Signup for full access
Browse free

VBIO Latest Earnings

The value each VBIO share was expected to gain vs. the value each share gained.

VBIO reported its most recent earnings on for Q3 2023, posting earnings per share (EPS) of -$25.16. This exceeded analysts' expectations of -$119 by 78.86%, marking a Beat.

For comparison, Tivic Health Systems Inc reported EPS of -$459 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

VBIO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026
Q4 2025
-$1.49
Q3 2025
-$2.00
Q2 2025
-$2.19
Q1 2025
-$2.52
View all

VBIO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Tivic Health Systems Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

VBIO Earnings FAQs

VBIO last reported earnings on Nov 14, 2023 for Q3 2023, posting an EPS of -$25.16, which Beat the estimate of -$119 by 78.86%.

For Q3 2023, VBIO reported an EPS of -$25.16, exceeding analysts' estimate of -$119 by 78.86%.

For Q3 2023, VBIO Beat expectations with an actual EPS of -$25.16 vs. an estimated EPS of -$119.

Following the last earnings report on Nov 14, 2023, VBIO's stock price moved — from — to —.

The next VBIO earnings call is scheduled for May. 18, 2026, where executives will discuss financial results and outlook.

Tivic Health Systems Inc (VBIO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.